Medicine supervisor bans turnover of some Indian preparations
The State Service of Ukraine for Medicines and Drugs Control has temporarily banned the sale and application of several preparations made by Genom Biotech Pvt. Ltd. (India).
The authority posted its resolution dated November 28 on its official website.
According to the resolution, the authority temporarily bans turnover of six Indian preparations LANZA, COFEX, SIGAN, ENZYMTAL, COLDFLU and TILDA.
In addition, the authority banned Espumisan preparation manufactured by Berlin-Chemie (Menarini Group, Germany) and Ringer's solution.
Advertising
Advertising
MORE ABOUT
Ukraine to secure additional EUR 100 mln from Council of Europe for healthcare reconstruction
20:42, 23.04.2024
Meeting with Swiss delegation held at President's Office
20:42, 17.04.2024
Almost 11,200 generators installed in Ukrainian clinics - Ministry of Health
09:54, 16.04.2024
Defense Ministry: Delegations of Ukraine, USA discuss training programs for military doctors
20:45, 12.04.2024
At least $14.2 bln needed to restore medical infrastructure destroyed by aggressor in Ukraine
18:51, 12.04.2024
LATEST
PM: preferential price for gas extended until end of summer, for electricity until end of spring
17:17, 26.04.2024
Work of Kyivteploenergo blocked due to new searches by law enforcers – company
13:00, 26.04.2024
Almost three-quarters of employers feel shortage of staff, plan to increase wages in 2024 – EBA survey
20:59, 25.04.2024
Metinvest's Pokrovske mine extracts 1.2 mln tonnes of coking coal in Q1, plan for 2024 is 5.35 mln tonnes
20:07, 25.04.2024
Chornomorsk port resumes shipment of agricultural products for export